Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication by Dostmann, Wolfgang R & Osborne, Brent W
ORAL PRESENTATION Open Access
Crystal structure of cGMP-dependent protein
kinase reveals novel site of interchain
communication
Wolfgang R Dostmann
*, Brent W Osborne
From 5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
Halle, Germany. 24-26 June 2011
Background
The cGMP-dependent protein kinase (PKG) is widely
expressed in mammalian tissues and serves as an inte-
gral component of second messenger signaling in a
number of biological contexts including vasodilation,
motility and memory [1]. PKG assembles into homodi-
mers [2] and large conformational changes are induced
by the cooperative binding of cGMP [2-4]. However, the
structure of PKG and the molecular mechanisms asso-
ciated with protomer communication following cGMP
binding remain obscure.
Results
Here we report the 2.5 Å crystal structure of a regula-
tory domain fragment containing both tandem cGMP
binding sites of PKG Ia (amino acids 78-355). The over-
all domain topology of this structure shows a distinct
and segregated architecture. The cGMP binding sites
are separated by an extended central helix and offer lim-
ited interdomain communication. However, a previously
uncharacterized helical domain (switch helix) promotes
the assembly of a dimeric interface between PKG Ia78-
355 protomers. Disruption of this interface by alanine
scanning mutagenesis in full length PKG resulted in a
marked reduction of activation constants.
Conclusion
Our results offer new insight about PKG holoenzyme
assembly as they provide the first detailed molecular
view of tandem cGMP-binding domains and character-
ize the switch helix as a critical site of interchain
communication between PKG protomers. The biologi-
cal integrity of PKG appears to be mediated by this
interface as it is necessary for the maintenance of
kinetic fidelity. This structure highlights the critical
importance of dimer communication in PKG biology
and will likely serve as an improved platform for the
strategic development of therapeutic agents aimed at
treatment and prevention of cGMP-dependent
pathologies.
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